search
search
Top

Jury sticks on to Hydroxychloroquine even after the Ambiguity

Even after the global tension over hydroxychloroquine and its ambiguous usages, the jury is still sticking on to its previous comment of saying it ‘game-changer.’ Even WHO has also got along with the remark of its problems in the treatment of COVID-19. WHO’s change of mind is a welcoming decision, says one of the leading scientists of Recovery trial, Martin Landray. It became a world favorite after the promotion by the US president. But several studies, including some leading universities of the world, have not declared any specific assurance of using it. There still needs a huge study to see whether the change of dosages can help the patients or not as it has already affected patients harmfully, staying in hospitals. Scientists and doctors are still not sure of the exact drug, which can be useful and apt for COVID-19. Unless the human trials are over, nothing is sure as for now.  

Post a Comment